Enhanced antisense oligonucleotides

Details for Australian Patent Application No. 2009251179 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Siwkowski, Andrew M.; Monia, Brett P.; Bhanot, Sanjay

Agent Pizzeys

Pub. Number AU-A-2009251179

Parent 2005286738

Filing date 24 December 2009

Wipo publication date 21 January 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A01N 43/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/88 (2006.01) Mutation or genetic engineering

C12P 19/34 (2006.01) Preparation of compounds containing saccharide radicals

Event Publications

21 January 2010 Application Open to Public Inspection

  Published as AU-A-2009251179

21 January 2010 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009251180-A gaming system and a method of gaming

2009251178-Method and nucleic acids for the improved treatment of breast cell proliferative disorders